This email address is being protected from spambots. You need JavaScript enabled to view it. 
+41 77 483 66 31
+ 7 495 991 86 63

R&D Company in Ophthalmology

The company developing a medicament for treatment of inflammatory eye diseases

 

Financial Information

The minimum level of investment for one investor: 2.000.000 CHF
The total amount of investment required  6.000.000 CHF

Description

The company developing a medicament for treatment of inflammatory eye diseases. IT rights are worldwide protected. Market potential is more than CHF 2 billion. After the first successfully closed investment round and the core investors in place, the company welcomes one more external investor for the following rounds. MOI is 10X and more.

The company will use funds for medical development of the product and clinical trials.

Project Location

Town: On demand

State: Valais

Country: Switzerland